Proteomic Modulation in TGF-β-Treated Cholangiocytes Induced by Curcumin Nanoparticles

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Curcumin, a polyphenol, has known anti-inflammatory, antioxidant, and hepato-protective effects.
• Poor water solubility and membrane permeability limit curcumin's therapeutic applications.
• Novel nanoformulations are being developed to enhance curcumin's bioavailability and efficacy.

Purpose of the Study:

• To prepare and characterize a water-stable, freely dispersible nanoformulation of curcumin.
• To investigate the effects of curcumin nanoformulation on cholangiocytes in a fibrotic model.
• To explore the proteomic changes induced by curcumin nanoformulation in transforming growth factor-β (TGF-β)-stimulated cholangiocytes.

Main Methods:

• Development and characterization of a curcumin nanoformulation.
• Establishment of an in vitro model of TGF-β-stimulated cholangiocytes.
• Application of Sequential Window Acquisition of All Theoretical Mass Spectra (SWATH-MS)-based quantitative proteomics to analyze proteome modulation.

Main Results:

• Curcumin nanoformulation confirmed anti-inflammatory properties and induced programmed cell death in cholangiocytes.
• The nanoformulation counteracted cellular damage induced by TGF-β.
• Positive modulation of proteins involved in TGF-β-mediated fibrosis was observed.

Conclusions:

• Curcumin nanoformulation demonstrates potential in mitigating cholangiocyte damage and fibrosis.
• The study provides a mechanistic understanding of curcumin's effects in fibrotic cholangiopathies.
• Results support the development of targeted therapies for cholangiopathies using curcumin nanoformulation.